The Diary for Immunotherapy of Malignant growth (JITC) is the open access, peer investigated diary that distributes on all parts of tumor immunology and disease immunotherapy, meaning to improve correspondence and advance logical comprehension in this quickly developing field. Subjects of intrigue extend over the fundamental science-translational-clinical range and incorporate tumor-have communications, the tumor micro environment, creature models, prescient and prognostic resistant biomarkers, novel pharmaceutical and cell treatments, antibodies, mix invulnerable based treatments, and safe related poisonousness.
As an approach to state thank you to the committed Society for Immunotherapy of Malignancy (SITC) individuals who resolutely work to propel the science and improve the lives of patients with disease, SITC will furnish individuals with a half markdown on article handling charges for all part composed 2020 distributions.
Research Article: Cancer Science & Therapy
Research Article: Cancer Science & Therapy
Research Article: Cancer Science & Therapy
Research Article: Cancer Science & Therapy
Research Article: Cancer Science & Therapy
Research Article: Cancer Science & Therapy
Research Article: Cancer Science & Therapy
Research Article: Cancer Science & Therapy
Editorial: Cancer Science & Therapy
Editorial: Cancer Science & Therapy
Scientific Tracks Abstracts: Nuclear Medicine & Radiation Therapy
Scientific Tracks Abstracts: Nuclear Medicine & Radiation Therapy
Scientific Tracks Abstracts: Pulmonary & Respiratory Medicine
Scientific Tracks Abstracts: Pulmonary & Respiratory Medicine
Scientific Tracks Abstracts: Journal of Nephrology & Therapeutics
Scientific Tracks Abstracts: Journal of Nephrology & Therapeutics
Scientific Tracks Abstracts: Journal of Bioengineering & Biomedical Science
Scientific Tracks Abstracts: Journal of Bioengineering & Biomedical Science
Cancer Science & Therapy received 5332 citations as per Google Scholar report